Overview
Announcements

Ordinary Adjustment | Solactive Global Genomics Immunology and Medical Revolution Index | Effective Date 2nd December 2025

Solactive Global Genomics Immunology and Medical Revolution Index:

In the ordinary adjustment, the following composition will be implemented effective open 2nd December 2025:

10X GENOMICS INC
ABBVIE INC
ADAPTIVE BIOTECHNOLOGIES CORP
AGILENT TECHNOLOGIES INC
AMGEN INC
ASCENTAGE PHARMA GROUP INTERNATIONAL
ASTRAZENECA PLC
AXSOME THERAPEUTICS INC
BEAM THERAPEUTICS INC
BEIGENE LTD
BIOGEN INC
BIONTECH SE
BRIDGEBIO PHARMA INC
BRISTOL-MYERS SQUIBB CO
CRISPR THERAPEUTICS AG
ELI LILLY & CO
EXACT SCIENCES CORP
GENEDX HOLDINGS CORP
GENMAB A/S
GENSCRIPT BIOTECH CORP
GILEAD SCIENCES INC
GUARDANT HEALTH INC
HUTCHMED CHINA LTD
IDEAYA BIOSCIENCES INC
ILLUMINA INC
INNOCARE PHARMA LTD
INTELLIA THERAPEUTICS INC
IOVANCE BIOTHERAPEUTICS INC
JOHNSON & JOHNSON
LEGEND BIOTECH CORP
LONZA GROUP AG
MERCK & CO. INC.
MODERNA INC
NATERA INC
PFIZER INC
PRECIGEN INC
PTC THERAPEUTICS INC
QIAGEN NV
RECURSION PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS
REVVITY INC
SAMSUNG BIOLOGICS CO LTD
SANOFI SA
SAREPTA THERAPEUTICS INC
SCHOLAR ROCK HOLDING CORP
SUMMIT THERAPEUTICS PLC
TEVA PHARMACEUTICAL IND LTD
TWIST BIOSCIENCE CORP
VERTEX PHARMACEUTICALS INC
VIKING THERAPEUTICS INC